December 6, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Franklin Resources, Inc. (“Franklin” or “the Company”) (NYSE: BEN). Investors who purchased Franklin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Franklin has violated… read more
December 4, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX). Investors who purchased Orthofix securities prior to October 11, 2022, and continue to hold to the present, are encouraged to obtain additional… read more
December 4, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprinklr, Inc. (“Sprinklr” or “the Company”) (NYSE: CXM). Investors who purchased Sprinklr securities prior to March 29, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
December 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Avid Bioservices, Inc. (“Avid”) (NASDAQ: CDMO) and GHO Capital Partners and Ampersand Capital Partners. Investors who purchased Avid and continue to hold to the present are encouraged to obtain additional information and assist the investigation…. read more
December 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Steel Connect, Inc. (“Steel Connect”) (NASDAQ: STCN) and Steel Partners Holdings L.P. (“Steel Partners”). Investors who purchased Steel Connect and continue to hold to the present are encouraged to obtain additional information and assist the… read more
November 25, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Macy’s, Inc. (“Macy’s” or “the Company”) (NYSE: M). Investors who purchased Macy’s securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Macy’s has violated federal… read more
November 25, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Macy’s, Inc. (“Macy’s” or “the Company”) (NYSE: M). Investors who purchased Macy’s securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Macy’s has violated federal… read more
November 22, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanterix Corporation (“Quanterix” or “the Company”) (NASDAQ: QTRX). Investors who purchased Quanterix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Quanterix has violated federal… read more
November 21, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Oklo Inc. (“Oklo” or “the Company”) (NYSE: OKLO). Investors who purchased Oklo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Oklo has violated federal… read more
November 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spyre Therapeutics, Inc. (“Spyre” or “the Company”) (NASDAQ: SYRE). Investors who purchased Spyre securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Spyre has violated… read more
November 13, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neurogene Inc. (“Neurogene” or “the Company”) (NASDAQ: NGNE). Investors who purchased Neurogene securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Neurogene has violated federal… read more
November 5, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. (“Extreme Networks” or “the Company”) (NASDAQ: EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged to… read more
October 31, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DZS, Inc. (“DZS” or “the Company”) (NASDAQ: DZSI). Investors who purchased DZS securities prior to March 10, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
October 30, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Janus International Group, Inc. (“Janus” or “the Company”) (NYSE: JBI). Investors who purchased Janus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Janus has… read more
October 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Unisys Corporation (“Unisys” or “the Company”) (NYSE: UIS). Investors who purchased Unisys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Unisys has violated federal… read more
October 20, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CSX Corporation (“CSX” or “the Company”) (NASDAQ: CSX). Investors who purchased CSX securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CSX has violated federal… read more
October 16, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or “the Company”) (NASDAQ: NVAX). Investors who purchased Novavax securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Novavax has violated federal… read more
October 16, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Biodexa Pharmaceuticals Plc (“Biodexa” or “the Company”) (NASDAQ: BDRX). Investors who purchased Biodexa securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Biodexa has violated… read more
October 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shattuck Labs, Inc. (“Shattuck” or “the Company”) (NASDAQ: STTK). Investors who purchased Shattuck securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Shattuck has violated… read more
October 14, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of First Solar, Inc. (“First Solar” or “the Company”) (NASDAQ: FSLR). Investors who purchased First Solar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether First… read more
October 9, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JFrog Ltd. (“JFrog” or “the Company”) (NASDAQ: FROG). Investors who purchased JFrog securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether JFrog has violated federal… read more
October 9, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Torrid Holdings Inc. (“Torrid” or “the Company”) (NYSE: CURV). Investors who purchased Torrid securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Torrid has violated… read more
October 7, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OpenSea NFTs. Investors who purchased OpenSea NFTs are encouraged to obtain additional information and assist the investigation. The investigation concerns whether OpenSea has violated federal securities laws. Investigation Details On August… read more
October 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nomura Holdings Inc ADR (“Nomura” or “the Company”) (NYSE: NMR). Investors who purchased Nomura securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nomura has… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SAP SE (“SAP” or “the Company”) (NYSE: SAP). Investors who purchased SAP securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether SAP has violated federal… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Light & Wonder, Inc. (“Light & Wonder” or “the Company”) (NASDAQ: LNW). Investors who purchased Light & Wonder securities are encouraged to obtain additional information and assist the investigation. The investigation… read more
September 26, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 2seventy bio, Inc. (“2seventy bio” or “the Company”) (NASDAQ: TSVT). Investors who purchased 2seventy bio securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether 2seventy… read more
September 23, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Winnebago Industries, Inc. (“Winnebago” or “the Company”) (NYSE: WGO). Investors who purchased Winnebago securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Winnebago has violated… read more
September 19, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. (“Progyny” or “the Company”) (NASDAQ: PGNY). Investors who purchased Progyny securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Progyny has violated federal… read more
September 18, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gogoro Inc. (“Gogoro” or “the Company”) (NASDAQ: GGR). Investors who purchased Gogoro securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gogoro has violated federal… read more